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Langerhans cells (LC) are a unique population of tissue-resident macrophages that form 
a network of cells across the epidermis of the skin, but which have the ability to migrate 
from the epidermis to draining lymph nodes (LN). Their location at the skin barrier sug-
gests a key role as immune sentinels. However, despite decades of research, the role of 
LC in skin immunity is unclear; ablation of LC results in neither fatal susceptibility to skin 
infection nor overt autoimmunity due to lack of immune regulation. Our understanding 
of immune processes has traditionally been centered on secondary lymphoid organs 
as sites of lymphocyte priming and differentiation, which is exemplified by LC, initially 
defined as a paradigm for tissue dendritic cells that migrate to draining LN on matura-
tion. But, more recently, an awareness of the importance of the tissue environment in 
shaping effector immunity has emerged. In this mini-review, we discuss whether our lack 
of understanding of LC function stems from our lymph node-centric view of these cells, 
and question whether a focus on LC as immune regulators in situ in the skin may reveal 
clearer answers about their function in cutaneous immunology.
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inTRODUCTiOn
Langerhans cells (LC) are a unique population of mononuclear phagocytes that are seeded from 
common macrophage precursors in the skin epidermis before birth (1) (and reviewed in this topic). 
They are highly conserved across vertebrate species (2, 3) and this, with their location at the interface 
with the environment, suggests the strategic importance of LC as immune sentinels at the skin bar-
rier surface.
Traditionally, immunologists have focused on secondary lymphoid organs as the center of T cell 
immunity, assuming that instructions given during the priming of naïve T cells by migratory and 
resident dendritic cells (DC) were sufficient for differentiation and effector function by T  cells 
recruited to peripheral sites of tissue injury. However, the field is beginning to appreciate importance 
of the tissue environment in regulating effector and regulatory T cell function, and it is clear that 
antigen-presenting cell-T cell interactions play a key role in T cell survival and function outside 
lymphoid organs (4). Despite sharing an origin with other tissue-resident macrophages, differentia-
tion of LC is associated with the acquisition of DC-like functions, namely the ability to migrate to 
skin-draining lymph nodes (LN) and interact with naïve T cells. Observation of this property in 
the 1980s has dominated the field, and as a result, studies to define LC function in the skin have 
focused largely on their role as DC-like cells in priming T  cell immunity [reviewed by Romani 
et al. (5)]. However, to date, a consistent role for LC as primers of T cell immunity has not emerged. 
FigURe 1 | Diagram illustrating known and predicted skin resident versus migratory roles for Langerhans cells (LC). LC have important functions as resident cells in 
the skin and as migratory cells to the lymph nodes (LN). Studies have largely focused on their potential importance in priming T cell immunity in LN; however, it is 
now appreciated that LC have many functions in situ in the skin. Demonstrated functions (shown in green) in the skin include interaction with resident memory 
T cells, clearance of apoptotic keratinocytes, licensing of effector T cell function, sentinel functions, and interaction with regulatory T cells. Data further suggest the 
potential for other macrophage-like functions of LC such as a role in the polarization of CD4+ T cells in situ (shown in red).
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In particular, there are few scenarios, if any, in which removal 
of LC ablates immunity to infection, or results in the develop-
ment of severe autoimmunity in mice; and, despite the common 
observation that LC are sufficient to prime T cell immunity after 
the experimental provision of antigen and adjuvants that may 
favor LC activation and migration [e.g., Ref. (6)], few papers 
have explicitly identified a crucial role for migratory LC, and not 
dermal DC, under physiological conditions.
We suggest that shifting our focus to potential roles for LC 
in situ in the skin, a function more in keeping with their devel-
opment as macrophages, will provide clearer answers about the 
importance of these unique cells in skin immunity. In this mini-
review, we will consider the evidence for LC functions within the 
skin (Figure  1), and discuss whether our historic focus on LC 
as exemplars of migrating DC has skewed our understanding of 
their role in skin immunity.
eLUCiDATing LC FUnCTiOn IN SITU  
in THe SKin
Barrier Site Surveillance
Sensing the Local Environment
Mononuclear phagocytes have important functions within tis-
sues, and barrier site non-migratory macrophages are essential 
for surveillance of the local environment. CX3CR1+ intestinal 
macrophages form dendritic projections, termed transepithelial 
dendrites, which penetrate the intestinal epithelium to sense 
commensal microbes and sample luminal antigens. Barrier integ-
rity is maintained by the formation of tight junctions between 
the macrophages and epithelial cells (7, 8). In the central nervous 
system, microglia are highly dynamic in their resting state and 
rapidly extend and retract their processes (9, 10). This motility, 
termed synaptic pruning, allows them to make frequent and 
transient contact with synapses, actively engulfing synaptic mate-
rial (11, 12), and is essential in nervous system development and 
maintenance (9, 13, 14).
Langerhans cells also constantly extend and retract dendrites 
between keratinocytes, in a behavior termed dendritic surveil-
lance extension and retraction cycling habitude (15). Barrier 
integrity is maintained by the de novo formation of tight junctions 
between keratinocytes and LC, enabling LC to sample the extra-
tight junction environment without loss of integrity (16). Thus, 
in this respect, LC can be seen to closely mimic non-migratory 
cells, leading to the question of how LC behavior compares to 
other resident macrophage populations once foreign material has 
been detected.
Local Interaction with Viruses
Langerhans cells are ideally positioned to respond to viruses that 
enter the body via the skin, namely human immunodeficiency 
virus (HIV), herpes viruses such as herpes simplex virus (HSV) 
or varicella zoster virus, and poxviruses (human papilloma 
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virus, HPV), and this interaction has been extensively reviewed 
elsewhere [e.g., Ref. (17–19)]. LC express a number of pattern 
recognition receptors but do not efficiently internalize bacteria 
in vitro, leading to the suggestion that they preferentially prime 
antiviral immunity (20, 21). However, infection of LC by HSV or 
HPV leads to their destruction; priming of T cell immunity in this 
situation probably depends on transfer of viral antigen to other 
DC. In the case of HSV, non-infected epidermal LC may acquire 
antigen from apoptotic LC in the skin and migrate to draining 
LN. Here, transfer of antigen to cross-presenting DC subsets 
is required for the initiation of CD8+ T cell immunity (22, 23). 
By comparison, while LC appear to be the major infected immune 
cell after HIV infection via the anogenital tract (24), there is 
evidence that they may restrict HIV replication or transmission 
(25, 26), and their protective role in HIV infection continues to 
be investigated (27). In this respect, LC resemble other tissue 
macrophages, which also restrict HIV and other viral infections 
(28, 29). Thus, LC may provide a repository of virally infected 
cells under some conditions, but the implications for this interac-
tion for innate and adaptive immunity still remain unclear.
innate Control of Skin immune 
Homeostasis
A key role for macrophages as resident tissue cells is the mainte-
nance of immune homeostasis. This occurs partly through their 
scavenger function, rapidly clearing debris from dying cells in 
the steady state and after infection. This uptake and recognition 
of apoptotic cells is an important mechanism for maintaining 
local immune tolerance to self-antigens (30, 31). TAM (TYRO3/
AXL/MER) family receptor tyrosine kinases are expressed by 
macrophages, DC and natural killer cells in the immune system. 
Engagement of the receptors by their ligands, growth-arrest-
specific (GAS)6, and protein S, enhances uptake of apoptotic cells 
and suppresses inflammation (32). In the gut, MER is upregulated 
by macrophages in response to induction of apoptosis in intraepi-
thelial cells, probably to control local immune suppression to 
self-antigens (31). LC employ a similar innate mechanism to 
control local tolerance in the skin: apoptotic keratinocytes 
accumulate in the skin of mice depleted of LC (33); and trans-
forming growth factor (TGF)-β induced expression of AXL by 
LC enhances uptake of GAS6-expressing apoptotic keratinocytes, 
inhibiting of production of inflammatory cytokines (34).
Regulation of T Cell Function in the Skin
In addition to innate control of the immune environment, tissue-
resident cells may also influence adaptive immunity by recruited 
regulatory and conventional T  cells. The following section 
considers the evidence for LC mediating this function directly 
in the skin.
Enhancing the Accumulation and Function  
of Regulatory T Cells In Situ
Tissue macrophages play a key role in the suppression of local 
adaptive immunity, via direct and indirect interaction with CD4+ 
regulatory T cells (Treg). CX3CR1-expressing macrophages are an 
abundant population in the lamina propria of the small intestine, 
where they regulate Treg differentiation in situ by production of 
IL-10, retinoid acid (RA) and TGF-β (35), and are critical for 
the local proliferation of Treg and induction of oral tolerance 
(36). Likewise, lung-resident tissue macrophages constitutively 
express TGF-β and RA to induce Treg within the lung tissue (37, 38), 
while IL-10 production by Kupffer cells in the liver, and microglia 
in the brain, has been implicated in the induction of Treg-induced 
tolerance (39–42). In addition to promoting cytokine-mediated 
differentiation and function, macrophages directly interact with 
Treg in situ. In a model of experimental autoimmune encephalo-
myelitis, direct contacts between sialoadhesin+ macrophages and 
Treg regulated local immune suppression to limit progression of 
disease (43), and in the liver, presentation of antigen and arrest of 
Treg by Kupffer cells led to local secretion of IL-10 (41).
Langerhans cells have been directly implicated in a number 
of Treg-dependent models of immune suppression in the skin 
but, consistent with the LN-centric view of LC research, it is 
often unclear whether cellular interactions between LC and 
Treg are occurring in the LN, the skin, or both. For example, 
while use of bone marrow chimeras in which radio-resistant 
LC are selectively deficient for the gene Cdkn1a suggests a clear 
role for LC in the priming of CD4+ Treg in LN after exposure 
to ionizing radiation (44), the precise location(s) at which LC 
are required has not been defined for the accumulation of Treg 
in the ear skin of Leishmania-infected mice (45), or expansion 
and function of activated ICOS+ Treg in a murine model of skin 
sensitization and tolerance (46). However, cognate interaction 
between LC and CD4+ T cells inhibits effector T cell responses 
after challenge with topical sensitizers (47), and resting LC from 
human skin selectively and specifically induce the activation 
and proliferation of skin resident Treg in vitro (48). Upregulation 
of receptor activator of nuclear factor κ B (RANK) ligand by 
apoptotic keratinocytes induces IL-10 production by LC (49), 
inferring the potential of LC to directly regulate effector T cell 
immunity in situ, after exposure to ultraviolet (UV)B radiation. 
This concept is supported by Loser et  al. who demonstrated 
that UV-induced immunosuppression is mediated by RANK-
RANKL signaling between LC and keratinocytes, resulting 
in an increased capacity of LC to induce IL-10-driven CD4+ 
Treg proliferation (50). CD300a is a glycoprotein expressed by 
myeloid cells, which binds phosphatidylserine when exposed 
on the plasma membrane of apoptotic cells. Interaction between 
CD300a+ LC and apoptotic epithelial cells in the skin restricts 
numbers of local Treg, mimicking interactions between epithelial 
cells and CD11b+CX3CR1+ cells in the lungs and gut. This interac-
tion was required for control of S. typhimurium in the gut, but 
promoted deleterious inflammatory responses including atopic 
dermatitis in the skin (51). Together, these data strongly support 
a tissue role for LC in controlling immune suppression by Treg.
Elegant in vivo imaging studies by the Germain lab recently 
revealed close localization of migrating dermal DC with Treg clus-
ters in mouse LN in the steady state (52), supporting a previous 
study that demonstrated a specific role for dermal RelB+ DC in the 
maintenance of skin tolerance (53). Given the sessile behavior of 
LC in the steady state (54), these data support a dominant role for 
dermal DC in maintaining day-to-day tolerance to skin antigens. 
Therefore, the challenge now is to understand whether there are 
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contexts in which LC may take over this regulatory role in LN. 
A recent study attempted to address this question using a novel 
genetic model of inducible neo-antigen expression by LC, but not 
other Langerin+ DC, in the steady state (LCre-GFPOVA mice) 
(55). In this model, presentation of endogenous ovalbumin leads 
to priming of CD8+ T cells in LN and accumulation of cutaneous 
CD4+ Treg. It would be informative to test how the Treg are primed 
in this model and whether LC are required for their suppressive 
function in the skin.
Activation of Effector T Cell Immunity in the Skin
While it is accepted that the tissue-immune environment is 
important for the differentiation and function of Treg, textbook 
immunology tells us that priming of naïve conventional T cells 
in LN provides all the requisite signals for differentiation into 
functional effector/memory T cells. However, numerous studies 
have now demonstrated the importance of interactions between 
myeloid cells and conventional T  cells for T  cell function and 
survival within peripheral tissues [reviewed in Ref. (4), see also 
Ref. (56)]. We have demonstrated a unique and novel role for LC 
in licensing effector function of CD8+ T cells in the epidermis 
(57). In this section, we will consider the evidence to suggest that 
LC may also drive the function of other effector T cells in situ.
Licensing of CD8+ T Cell Function by LC
Langerhans cells are highly radio-resistant and, as such, persist 
following conditioning of patients prior to allogeneic stem cell 
transplantation for blood cancers and other hematopoietic 
diseases. Entry of activated donor T cells into inflamed organs, 
including the skin, frequently leads to graft-versus-host disease 
(GVHD) in these patients (reviewed in this topic by Santos e 
Sousa and Chakraverty). LC are sufficient to prime the donor 
T cell response leading to GVHD (58), but are not required for 
systemic GVHD in the presence of conventional DC populations 
(59). To understand whether LC are important in cutaneous 
GVHD, we combined the Langerin-diphtheria toxin receptor 
model [in which LC are inducibly depleted upon injection of 
diphtheria toxin (60)] with a murine allogeneic model of GVHD 
(61). We demonstrated that LC were not required for priming of 
donor T  cells, in agreement with the published literature (59). 
However, when we focused on the cellular interactions occur-
ring in the skin, we observed that LC licensed the upregulation 
of epidermal effector CD8+ T cell function, leading to GVHD at 
the site of inflammation (57). This research, therefore, revealed a 
novel role for LC outside LN.
LC-Dependent Control of CD4+ T Cell Function
Polarized CD4+ T cells that exit LN after priming maintain the 
plasticity to adapt to the tissue environment at their destination 
(62). This is particularly true for Th17 cells that may acquire a 
different functional fate depending on signals received from their 
surroundings. IL-23 production by monocytes and macrophages 
in inflamed tissues has been closely linked to the activation of 
IL-17-producing CD4+ T cells [e.g., Ref. (63–65)], and Foucher 
et al. demonstrated that interaction between human macrophages 
and memory CD4+ T cells via membrane-bound IL-1α is suffi-
cient to polarize T cells toward Th1 or Th17-like phenotypes (66). 
Moreover, “inflammatory DC” from patient synovial fluid or 
tumor ascites stimulate IL-17 production from autologous CD4+ 
T cells, suggesting that myeloid cells may directly induce differ-
entiation of Th17 cells within tissues (67).
Based on these macrophage data, it seems likely that LC 
perform a similar role in the skin, and it is clear that activated 
LC produce Th17-polarizing cytokines ex vivo (68–70). However, 
the ability of LC to induce differentiation and activation of epi-
dermal Th17 cells in situ has not been directly investigated. LC 
are required for the priming of Th17 cells in response to topical 
Candida albicans infection (71, 72), and for the accumulation 
of both IL-17+CD4+ αβ and γδ T cells in the epidermis of mice 
with Staphylococcus aureus dysbiosis (73); however, neither 
study investigated whether LC are required in  situ for the 
functional activity of cutaneous Th17  cells. Likewise, there are 
currently conflicting data on whether IL-23 production by LC 
is important for IL-17-dependent psoriasis-like disease (74, 75), 
and, to date, studies have focused on an Imiquimod-driven, αβ 
T cell-independent, γδ T cell-dependent model of disease. Thus, 
the potential importance of interactions between LC and epider-
mal CD4+ T cells in psoriasis has not been established.
LC and Cutaneous-Resident Memory T Cells
Human skin contains billions of T cells, and the majority express 
markers associated with retention as resident memory cells (Trm) 
(76). The concept of LC eliciting rapid localized immunity via 
activation of these cells is, therefore, very attractive. Precedent for 
interaction between tissue macrophages and Trm has been set in 
the vaginal mucosa, where macrophage-derived CCL5 is required 
for the recruitment and maintenance of clusters of CD4+ Trm that 
protect against viral challenge (77). However, despite evidence 
that LC interact directly with CD4+ memory T cells in human 
skin (48), and data demonstrating that LC interact with, and may 
control local migration of Trm within the epidermis (78), forma-
tion of CD8+ Trm is not impaired in the absence of LC (79).
IL-17 production by human skin Trm is associated with 
psoriasis (80). However, a subsequent study from the same lab 
demonstrated that incubation with IL-6, IL-1β, and IL-23 were 
not sufficient in vitro to induce IL-17 production by CD8+ Trm 
from healthy skin, suggesting a requirement for cognate T cell 
receptor-mediated interactions in situ (81). These data strongly 
infer a role for local interactions with LC, or other epidermal cells, 
in controlling Trm fate in the context of autoimmunity.
COnCLUDing ReMARKS: wHY DO LC 
evOLve THe CAPACiTY TO MigRATe?
Despite the development of LC from a common macrophage 
precursor (1), transcriptional profiling demonstrates a gene 
expression profile that is more similar to migrating DC than 
other macrophage populations (3, 82), and LC share an antigen 
processing and presentation machinery with DC (83). Resident 
macrophage precursors that are recruited into different sites 
respond to tissue-specific signals and differentiate into a func-
tional cell type that is adapted to that niche (84). For example, 
lung macrophages develop the capacity to phagocytose excessive 
5West and Bennett Redefining LC Function in the Skin
Frontiers in Immunology | www.frontiersin.org January 2018 | Volume 8 | Article 1941
surfactant proteins, thereby preventing alveolar proteinosis 
(85). These observations lead us to anticipate the existence of 
environmental pressures in the epidermis leading to functional 
evolution of LC toward a DC-like cell. However, given the 
paucity of data showing a clear requirement for LC in priming 
immunity to infections, and the frequency of DC in the dermis, 
the unanswered question remains of why the acquisition of a 
DC-like function by LC is so important for protection of the 
organism?
Egress of LC from the keratinocyte network in the epidermis 
to LN is a carefully choreographed process. In the epidermis, 
inflammation and/or pathogen-derived signals block TGF-β-
mediated retention by integrins (79, 86) and promote down-
regulation of the cell adhesion protein E-cadherin (87), together 
allowing release of LC from surrounding keratinocytes. Activated 
LC then secrete metalloproteinases (MMP) 2 and 9, required to 
break though the basement membrane and enter the dermis (88). 
Once in the dermis, LC upregulate the chemokine receptor CCR7 
that conducts entry into the dermal lymphatics (89, 90), mirror-
ing the migratory pathway used by tissue DC to enter LN.
The requirement to extricate themselves from the keratino-
cyte network in the epidermis means that LC are slower to 
arrive in draining LN than dermal DC after antigenic chal-
lenge, suggesting that dermal DC may dominate in priming 
T  cell responses to antigens that enter the dermis (54, 91). 
However, there are scenarios in which LC appear to take charge. 
Epicutaneous infection models with the pathogens C. albicans 
or S. aureus have demonstrated clear roles for LC in priming 
protective CD4+ T  cell responses (71, 72, 92), and ionizing 
radiation specifically activates LC to prime Treg in LN (44). 
Human, but not murine, LC express high levels of the invari-
ant MHC-like molecule, CD1a. Recognition of CD1a on LC by 
recruited autoreactive T cells, or T cells specific for the poison 
ivy lipid urushiol, results in enhanced activation of IL-22- or 
IL-17-producing CD4+ T cells, respectively (93, 94). These data 
support murine studies suggesting that LC prime CD4+ T cells 
responses to some topically applied sensitizers that do not reach 
the dermis (95, 96), potentially demonstrating a requirement 
for migratory epidermal cells in the rapid initiation of T  cell 
responses to topical sensitizers or irritants.
Langerhans cells have also emerged as key players in the acti-
vation of CD4+ T follicular helper cells (Tfh), which are required 
for germinal center formation and antibody affinity maturation 
in response to infection or vaccination (97). Here, ablation of 
LC results in clear defects in the formation of germinal centers 
and production of mature antibodies (92, 98). Importantly, this 
requirement for LC persists when antigen is delivered into the 
dermis and, therefore, should theoretically be preferentially 
acquired by dermal DC (97, 99). By contrast, an alternative 
study demonstrated that loss of LC led to increased production 
of autoantibodies in a murine model of lupus dermatitis (100), 
implying that, under steady state conditions, LC may also regulate 
activation of Tfh, either directly or indirectly via Treg. However, 
dermal DC also prime Tfh (101), indicating that the need to 
generate antibody responses to skin antigens is not a sufficient 
functional pressure to explain the acquisition of migratory func-
tion by LC.
In conclusion we argue that, while significant progress has 
been made in our understanding of the key role LC play in cuta-
neous immunity, we now need to shift our focus from LN to the 
skin. Precise definition of the sites of interaction between LC and 
T cells, or other cells, is needed to determine the selective pres-
sures that drive the relative tissue-resident or migratory DC-like 
functions of these unique cells.
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